{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:17:02Z","timestamp":1792459022639,"version":"4.5.0"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Insights Imaging"],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>For over 20 years, the two key tenets of adrenal incidentaloma (AI) evaluation have been the upper threshold of 10 Hounsfield units (HU) on noncontrast CT (ncCT) to delineate benignity, and the utilisation of adrenal washout CT (AWCT) to evaluate those above this cutoff. In light of growing recent evidence that challenges these two traditional principles, as well as re-evaluation of the data that led to their acceptance, we conclude that neither of these mainstays of adrenal CT remains relevant in modern AI diagnostic workup. With an appropriate definition of an incidentaloma and endocrine assessment for the majority of adrenal lesions, our analysis establishes that the use of AWCT should be ceased in the assessment of AIs, and that a 20 HU attenuation threshold for lesions &lt; 4\u2009cm should replace the traditional 10 HU threshold to exclude malignancy in this patient population. We therefore propose new recommendations for the management of AIs based primarily on CT attenuation and lesion size on ncCT.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Critical relevance statement<\/jats:title>\n            <jats:p>Increasing the CT attenuation threshold to 20 HU for lesions &lt; 4\u2009cm and eliminating washout CT for true adrenal incidentalomas, together with recommendations for endocrine assessment, will significantly decrease the over-investigation of overwhelmingly benign adrenal lesions, whilst confidently excluding malignancy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Key Points<\/jats:title>\n            <jats:p>\n              <jats:list list-type=\"bullet\">\n                <jats:list-item>\n                  <jats:p>True incidentalomas exclude current or prior extra-adrenal malignancy and clinically suspected adrenal disease.<\/jats:p>\n                <\/jats:list-item>\n                <jats:list-item>\n                  <jats:p>Adrenal washout CT was never proven in the malignancy-sparse true incidentaloma population.<\/jats:p>\n                <\/jats:list-item>\n                <jats:list-item>\n                  <jats:p>Hormonal correlation in parallel with &lt; 20 HU and &lt; 4\u2009 cm thresholds of homogeneous lesions on noncontrast CT excludes malignancy.<\/jats:p>\n                <\/jats:list-item>\n              <\/jats:list>\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical Abstract<\/jats:title>\n          <\/jats:sec>","DOI":"10.1186\/s13244-025-02015-4","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T15:35:15Z","timestamp":1751038515000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Washed up: the end of an era for adrenal incidentaloma CT"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3534-8109","authenticated-orcid":false,"given":"James H.","family":"Seow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien L.","family":"Stella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Welman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjuna J.","family":"Somasundaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan F.","family":"Gerstenmaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,27]]},"reference":[{"key":"2015_CR1","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1148\/radiol.2223010766","volume":"222","author":"EM Caoili","year":"2002","unstructured":"Caoili EM, Korobkin M, Francis IR et al (2002) Adrenal masses: characterization with combined unenhanced and delayed enhanced CT. Radiology 222:629\u2013633. https:\/\/doi.org\/10.1148\/radiol.2223010766","journal-title":"Radiology"},{"key":"2015_CR2","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.jacr.2017.05.001","volume":"14","author":"WW Mayo-Smith","year":"2017","unstructured":"Mayo-Smith WW, Song JH, Boland GL et al (2017) Management of incidental adrenal masses: a white paper of the ACR Incidental Findings Committee. J Am Coll Radiol 14:1038\u20131044. https:\/\/doi.org\/10.1016\/j.jacr.2017.05.001","journal-title":"J Am Coll Radiol"},{"key":"2015_CR3","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1093\/ejendo\/lvad066","volume":"189","author":"M Fassnacht","year":"2023","unstructured":"Fassnacht M, Tsagarakis S, Terzolo M (2023) European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol 189:G1\u2013G42. https:\/\/doi.org\/10.1093\/ejendo\/lvad066","journal-title":"Eur J Endocrinol"},{"key":"2015_CR4","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3803\/EnM.2017.32.2.200","volume":"32","author":"JM Lee","year":"2017","unstructured":"Lee JM, Kim MK, Ko SH et al (2017) Clinical guidelines for the management of adrenal incidentaloma. Endocrinol Metab 32:200\u2013218. https:\/\/doi.org\/10.3803\/EnM.2017.32.2.200","journal-title":"Endocrinol Metab"},{"key":"2015_CR5","doi-asserted-by":"publisher","first-page":"12","DOI":"10.5489\/cuaj.8248","volume":"17","author":"NE Rowe","year":"2023","unstructured":"Rowe NE, Kumar RM, Schieda N et al (2023) Canadian Urological Association guideline: diagnosis, management, and followup of the incidentally discovered adrenal mass. Can Urol Assoc J 17:12\u201324. https:\/\/doi.org\/10.5489\/cuaj.8248","journal-title":"Can Urol Assoc J"},{"key":"2015_CR6","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/BF03344099","volume":"29","author":"S Bovio","year":"2006","unstructured":"Bovio S, Cataldi A, Reimondo G et al (2006) Prevalence of adrenal incidentaloma in a contemporary computerized tomography series. J Endocrinol Invest 29:298\u2013302. https:\/\/doi.org\/10.1007\/BF03344099","journal-title":"J Endocrinol Invest"},{"key":"2015_CR7","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3109\/02841851.2010.516016","volume":"51","author":"L Hammarstedt","year":"2010","unstructured":"Hammarstedt L, Muth A, W\u00e4ngberg B et al (2010) Adrenal lesion frequency: a prospective, cross-sectional CT study in a defined region, including systematic re-evaluation. Acta Radiol 51:1149\u20131156. https:\/\/doi.org\/10.3109\/02841851.2010.516016","journal-title":"Acta Radiol"},{"key":"2015_CR8","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.2214\/AJR.07.2799","volume":"190","author":"JH Song","year":"2008","unstructured":"Song JH, Chaudhry FS, Mayo-Smith WW (2008) The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. AJR Am J Roentgenol 190:1163\u20131168. https:\/\/doi.org\/10.2214\/AJR.07.2799","journal-title":"AJR Am J Roentgenol"},{"key":"2015_CR9","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3109\/0284186X.2011.608084","volume":"51","author":"L Hammarstedt","year":"2012","unstructured":"Hammarstedt L, Muth A, Sigurj\u00f3nsd\u00f3ttir H\u00c1, Almqvist E, W\u00e4ngberg B, Hellstr\u00f6m M (2012) Adrenal lesions in patients with extra-adrenal malignancy\u2014benign or malignant? Acta Oncol 51:215\u2013221. https:\/\/doi.org\/10.3109\/0284186X.2011.608084","journal-title":"Acta Oncol"},{"key":"2015_CR10","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1007\/s00261-022-03729-5","volume":"48","author":"DI Glazer","year":"2023","unstructured":"Glazer DI, Mayo-Smith WW, Remer EM et al (2023) Lexicon for adrenal terms at CT and MRI: a consensus of the Society of Abdominal Radiology adrenal neoplasm disease-focused panel. Abdom Radiol (NY) 48:952\u2013975. https:\/\/doi.org\/10.1007\/s00261-022-03729-5","journal-title":"Abdom Radiol (NY)"},{"key":"2015_CR11","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1007\/s00261-021-03405-0","volume":"47","author":"MK Kim","year":"2022","unstructured":"Kim MK, Kang KA, Park SY (2022) Clinical significance of a 10-mm cutoff size for adrenal lesions: a retrospective study with 547 non-oncologic patients undergoing adrenal computed tomography. Abdom Radiol (NY) 47:1091\u20131097. https:\/\/doi.org\/10.1007\/s00261-021-03405-0","journal-title":"Abdom Radiol (NY)"},{"key":"2015_CR12","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S0022-5347(17)76948-0","volume":"34","author":"GF Cahill","year":"1935","unstructured":"Cahill GF (1935) Air injections to demonstrate the adrenals by X-ray. J Urol 34:238\u2013243. https:\/\/doi.org\/10.1016\/S0022-5347(17)76948-0","journal-title":"J Urol"},{"key":"2015_CR13","first-page":"66","volume":"15","author":"JN Watt-Wyness","year":"1949","unstructured":"Watt-Wyness JN (1949) Adrenal gland investigation by air-insufflation tomography. Radiography 15:66","journal-title":"Radiography"},{"key":"2015_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2214\/ajr.127.1.23","volume":"127","author":"PF Sheedy 2nd","year":"1976","unstructured":"Sheedy PF 2nd, Stephens DH, Hattery RR, Muhm JR, Hartman GW (1976) Computed tomography of the body: initial clinical trial with the EMI prototype. AJR Am J Roentgenol 127:23\u201351. https:\/\/doi.org\/10.2214\/ajr.127.1.23","journal-title":"AJR Am J Roentgenol"},{"key":"2015_CR15","doi-asserted-by":"publisher","first-page":"993","DOI":"10.2214\/ajr.129.6.993","volume":"129","author":"M Behan","year":"1977","unstructured":"Behan M, Martin EC, Muecke EC, Kazam E (1977) Myelolipoma of the adrenal: two cases with ultrasound and CT findings. AJR Am J Roentgenol 129:993\u2013996. https:\/\/doi.org\/10.2214\/ajr.129.6.993","journal-title":"AJR Am J Roentgenol"},{"key":"2015_CR16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/00004728-197801000-00002","volume":"2","author":"EG Schaner","year":"1978","unstructured":"Schaner EG, Dunnick NR, Doppman JL, Strott CA, Gill JR Jr, Javadpour N (1978) Adrenal cortical tumors with low attenuation coefficients: a pitfall in computed tomography diagnosis. J Comput Assist Tomogr 2:11\u201315. https:\/\/doi.org\/10.1097\/00004728-197801000-00002","journal-title":"J Comput Assist Tomogr"},{"key":"2015_CR17","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.2214\/ajr.152.5.1005","volume":"152","author":"H Miyake","year":"1989","unstructured":"Miyake H, Maeda H, Tashiro M (1989) CT of adrenal tumors: frequency and clinical significance of low-attenuation lesions. AJR Am J Roentgenol 152:1005\u20131007. https:\/\/doi.org\/10.2214\/ajr.152.5.1005","journal-title":"AJR Am J Roentgenol"},{"key":"2015_CR18","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1148\/radiology.179.2.2014283","volume":"179","author":"MJ Lee","year":"1991","unstructured":"Lee MJ, Hahn PF, Papanicolaou N (1991) Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis. Radiology 179:415\u2013418. https:\/\/doi.org\/10.1148\/radiology.179.2.2014283","journal-title":"Radiology"},{"key":"2015_CR19","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2214\/ajr.171.1.9648789","volume":"171","author":"GW Boland","year":"1998","unstructured":"Boland GW, Lee MJ, Gazelle GS, Halpern EF, McNicholas MM, Mueller PR (1998) Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. AJR Am J Roentgenol 171:201\u2013204. https:\/\/doi.org\/10.2214\/ajr.171.1.9648789","journal-title":"AJR Am J Roentgenol"},{"key":"2015_CR20","doi-asserted-by":"publisher","first-page":"450","DOI":"10.4158\/EP.15.5.450","volume":"15","author":"MA Zeiger","year":"2009","unstructured":"Zeiger MA, Thompson GB, Duh QY et al (2009) American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons medical guidelines for the management of adrenal incidentalomas: executive summary of recommendations. Endocr Pract 15:450\u2013453. https:\/\/doi.org\/10.4158\/EP.15.5.450","journal-title":"Endocr Pract"},{"key":"2015_CR21","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.jacr.2010.06.013","volume":"7","author":"LL Berland","year":"2010","unstructured":"Berland LL, Silverman SG, Gore RM et al (2010) Managing incidental findings on abdominal CT: white paper of the ACR incidental findings committee. J Am Coll Radiol 7:754\u2013773. https:\/\/doi.org\/10.1016\/j.jacr.2010.06.013","journal-title":"J Am Coll Radiol"},{"key":"2015_CR22","doi-asserted-by":"publisher","first-page":"241","DOI":"10.5489\/cuaj.11135","volume":"5","author":"A Kapoor","year":"2012","unstructured":"Kapoor A, Morris T, Rebello R (2012) Guidelines for the management of the incidentally discovered adrenal mass. Can Urol Assoc J 5:241\u2013247. https:\/\/doi.org\/10.5489\/cuaj.11135. Erratum in: Can Urol Assoc J 6:244. doi: 10.5489\/cuaj.12208","journal-title":"Can Urol Assoc J"},{"key":"2015_CR23","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-16-0467","volume":"175","author":"M Fassnacht","year":"2016","unstructured":"Fassnacht M, Arlt W, Bancos I et al (2016) Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol 175:G1\u2013G34. https:\/\/doi.org\/10.1530\/EJE-16-0467","journal-title":"Eur J Endocrinol"},{"key":"2015_CR24","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1148\/radiology.171.3.2717737","volume":"171","author":"GP Krestin","year":"1989","unstructured":"Krestin GP, Steinbrich W, Friedmann G (1989) Adrenal masses: evaluation with fast gradient-echo MR imaging and Gd-DTPA-enhanced dynamic studies. Radiology 171:675\u2013680. https:\/\/doi.org\/10.1148\/radiology.171.3.2717737","journal-title":"Radiology"},{"key":"2015_CR25","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/00004728-199101000-00016","volume":"15","author":"GP Krestin","year":"1991","unstructured":"Krestin GP, Freidmann G, Fishbach R, Neufang KF, Allolio B (1991) Evaluation of adrenal masses in oncologic patients: dynamic contrast-enhanced MR vs CT. J Comput Assist Tomogr 15:104\u2013110. https:\/\/doi.org\/10.1097\/00004728-199101000-00016","journal-title":"J Comput Assist Tomogr"},{"key":"2015_CR26","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/s0009-9260(05)83419-1","volume":"50","author":"T Ichikawa","year":"1995","unstructured":"Ichikawa T, Ohtomo K, Uchiyama G, Fujimoto H, Nasu K (1995) Contrast-enhanced dynamic MRI of adrenal masses: classification of characteristic enhancement patterns. Clin Radiol 50:295\u2013300. https:\/\/doi.org\/10.1016\/s0009-9260(05)83419-1","journal-title":"Clin Radiol"},{"key":"2015_CR27","doi-asserted-by":"publisher","first-page":"531","DOI":"10.2214\/ajr.166.3.8623622","volume":"166","author":"M Korobkin","year":"1996","unstructured":"Korobkin M, Brodeur FJ, Yutzy GG et al (1996) Differentiation of adrenal adenomas from nonadenomas using CT attenuation values. AJR Am J Roentgenol 166:531\u2013536. https:\/\/doi.org\/10.2214\/ajr.166.3.8623622","journal-title":"AJR Am J Roentgenol"},{"key":"2015_CR28","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1148\/radiology.200.3.8756924","volume":"200","author":"M Korobkin","year":"1996","unstructured":"Korobkin M, Brodeur FJ, Francis IR, Quint LE, Dunnick NR, Goodsitt M (1996) Delayed enhanced CT for differentiation of benign from malignant adrenal masses. Radiology 200:737\u2013742. https:\/\/doi.org\/10.1148\/radiology.200.3.8756924","journal-title":"Radiology"},{"key":"2015_CR29","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1148\/radiology.202.2.9015083","volume":"202","author":"DH Szolar","year":"1997","unstructured":"Szolar DH, Kammerhuber F (1997) Quantitative CT evaluation of adrenal gland masses: a step forward in the differentiation between adenomas and nonadenomas? Radiology 202:517\u2013521. https:\/\/doi.org\/10.1148\/radiology.202.2.9015083","journal-title":"Radiology"},{"key":"2015_CR30","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1148\/radiology.202.3.9051018","volume":"202","author":"GW Boland","year":"1997","unstructured":"Boland GW, Hahn PF, Pe\u00f1a C, Mueller PR (1997) Adrenal masses: characterization with delayed contrast-enhanced CT. Radiology 202:693\u2013696. https:\/\/doi.org\/10.1148\/radiology.202.3.9051018","journal-title":"Radiology"},{"key":"2015_CR31","doi-asserted-by":"publisher","first-page":"747","DOI":"10.2214\/ajr.170.3.9490968","volume":"170","author":"M Korobkin","year":"1998","unstructured":"Korobkin M, Brodeur FJ, Francis IR, Quint LE, Dunnick NR, Londy F (1998) CT time-attenuation washout curves of adrenal adenomas and nonadenomas. AJR Am J Roentgenol 170:747\u2013752. https:\/\/doi.org\/10.2214\/ajr.170.3.9490968","journal-title":"AJR Am J Roentgenol"},{"key":"2015_CR32","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1148\/radiology.207.2.9577483","volume":"207","author":"DH Szolar","year":"1998","unstructured":"Szolar DH, Kammerhuber FH (1998) Adrenal adenomas and nonadenomas: assessment of washout at delayed contrast-enhanced CT. Radiology 207:369\u2013375. https:\/\/doi.org\/10.1148\/radiology.207.2.9577483","journal-title":"Radiology"},{"key":"2015_CR33","first-page":"385","volume":"46","author":"R Gendy","year":"2017","unstructured":"Gendy R, Rashid P (2017) Incidental adrenal masses\u2014a primary care approach. Aust Fam Physician 46:385\u2013390","journal-title":"Aust Fam Physician"},{"key":"2015_CR34","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/JU.0000000000001342","volume":"205","author":"M Maas","year":"2021","unstructured":"Maas M, Nassiri N, Bhanvadia S, Carmichael JD, Duddalwar V, Daneshmand S (2021) Discrepancies in the recommended management of adrenal incidentalomas by various guidelines. J Urol 205:52\u201359. https:\/\/doi.org\/10.1097\/JU.0000000000001342. Erratum in: J Urol 205:942","journal-title":"J Urol"},{"key":"2015_CR35","unstructured":"BMJ Best Practice (2023) Assessment of incidental adrenal mass. Available via https:\/\/bestpractice.bmj.com\/topics\/en-gb\/518\/pdf\/518\/Assessment%20of%20incidental%20adrenal%20mass.pdf. Accessed 4 Dec 2024"},{"key":"2015_CR36","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1210\/jcem.85.2.6372","volume":"85","author":"F Mantero","year":"2000","unstructured":"Mantero F, Terzolo M, Arnaldi G et al (2000) A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab 85:637\u2013644. https:\/\/doi.org\/10.1210\/jcem.85.2.6372","journal-title":"J Clin Endocrinol Metab"},{"key":"2015_CR37","doi-asserted-by":"publisher","first-page":"e238","DOI":"10.1097\/SLA.0000000000004048","volume":"275","author":"B Kahramangil","year":"2022","unstructured":"Kahramangil B, Kose E, Remer EM et al (2022) A modern assessment of cancer risk in adrenal incidentalomas: analysis of 2219 patients. Ann Surg 275:e238\u2013e244. https:\/\/doi.org\/10.1097\/SLA.0000000000004048","journal-title":"Ann Surg"},{"key":"2015_CR38","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1530\/EJE-18-0006","volume":"178","author":"E Buitenwerf","year":"2018","unstructured":"Buitenwerf E, Korteweg T, Visser A (2018) Unenhanced CT imaging is highly sensitive to exclude pheochromocytoma: a multicenter study. Eur J Endocrinol 178:431\u2013437. https:\/\/doi.org\/10.1530\/EJE-18-0006","journal-title":"Eur J Endocrinol"},{"key":"2015_CR39","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1210\/jc.2012-1061","volume":"97","author":"T Sane","year":"2012","unstructured":"Sane T, Schalin-J\u00e4ntti C, Raade M (2012) Is biochemical screening for pheochromocytoma in adrenal incidentalomas expressing low unenhanced attenuation on computed tomography necessary? J Clin Endocrinol Metab 97:2077\u20132083. https:\/\/doi.org\/10.1210\/jc.2012-1061","journal-title":"J Clin Endocrinol Metab"},{"key":"2015_CR40","doi-asserted-by":"publisher","first-page":"122","DOI":"10.2214\/AJR.12.9620","volume":"201","author":"J Patel","year":"2013","unstructured":"Patel J, Davenport MS, Cohan RH, Caoili EM (2013) Can established CT attenuation and washout criteria for adrenal adenoma accurately exclude pheochromocytoma? AJR Am J Roentgenol 201:122\u2013127. https:\/\/doi.org\/10.2214\/AJR.12.9620","journal-title":"AJR Am J Roentgenol"},{"key":"2015_CR41","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3803\/EnM.2015.30.4.481","volume":"30","author":"C Schalin-J\u00e4ntti","year":"2015","unstructured":"Schalin-J\u00e4ntti C, Raade M, H\u00e4m\u00e4l\u00e4inen E, Sane T (2015) A 5-year prospective follow-up study of lipid-rich adrenal incidentalomas: no tumor growth or development of hormonal hypersecretion. Endocrinol Metab 30:481\u2013487. https:\/\/doi.org\/10.3803\/EnM.2015.30.4.481","journal-title":"Endocrinol Metab"},{"key":"2015_CR42","doi-asserted-by":"publisher","first-page":"e1948","DOI":"10.1097\/MD.0000000000001948","volume":"94","author":"JH Jun","year":"2015","unstructured":"Jun JH, Ahn HJ, Lee SM et al (2015) Is preoperative biochemical testing for pheochromocytoma necessary for all adrenal incidentalomas? Medicine (Baltimore) 94:e1948. https:\/\/doi.org\/10.1097\/MD.0000000000001948","journal-title":"Medicine (Baltimore)"},{"key":"2015_CR43","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1016\/j.mayocp.2019.03.030","volume":"94","author":"E Buitenwerf","year":"2019","unstructured":"Buitenwerf E, Berends AMA, van Asselt ADI et al (2019) Diagnostic accuracy of computed tomography to exclude pheochromocytoma: a systematic review, meta-analysis, and cost analysis. Mayo Clin Proc 94:2040\u20132052. https:\/\/doi.org\/10.1016\/j.mayocp.2019.03.030","journal-title":"Mayo Clin Proc"},{"key":"2015_CR44","doi-asserted-by":"publisher","first-page":"e389","DOI":"10.1210\/clinem\/dgad401","volume":"109","author":"S Aggarwal","year":"2023","unstructured":"Aggarwal S, Prete A, Chortis V et al (2023) Pheochromocytomas most commonly present as adrenal incidentalomas: a large tertiary center experience. J Clin Endocrinol Metab 109:e389\u2013e396. https:\/\/doi.org\/10.1210\/clinem\/dgad401","journal-title":"J Clin Endocrinol Metab"},{"key":"2015_CR45","doi-asserted-by":"publisher","first-page":"2910","DOI":"10.1007\/s00261-020-02517-3","volume":"45","author":"MT Corwin","year":"2020","unstructured":"Corwin MT, Arora A, Loehfelm TW, Fananapazir G, Campbell MJ (2020) Adherence to guidelines for hormonal evaluation in patients with incidentally detected adrenal nodules: effects of radiology report wording and standardized reporting. Abdom Radiol (NY) 45:2910\u20132915. https:\/\/doi.org\/10.1007\/s00261-020-02517-3","journal-title":"Abdom Radiol (NY)"},{"key":"2015_CR46","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s00330-017-5076-5","volume":"28","author":"S Woo","year":"2018","unstructured":"Woo S, Suh CH, Kim SY, Cho JY, Kim SH (2018) Pheochromocytoma as a frequent false-positive in adrenal washout CT: a systematic review and meta-analysis. Eur Radiol Mar 28:1027\u20131036. https:\/\/doi.org\/10.1007\/s00330-017-5076-5","journal-title":"Eur Radiol Mar"},{"key":"2015_CR47","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1177\/0284185119889568","volume":"61","author":"E Altinmakas","year":"2020","unstructured":"Altinmakas E, Perrier ND, Grubbs EG, Lee JE, Prieto VG, Ng CS (2020) Diagnostic performance of adrenal CT in the differentiation of adenoma and pheochromocytoma. Acta Radiol 61:1080\u20131086. https:\/\/doi.org\/10.1177\/0284185119889568","journal-title":"Acta Radiol"},{"key":"2015_CR48","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1210\/jc.2018-01532","volume":"104","author":"L Canu","year":"2019","unstructured":"Canu L, Van Hemert JAW, Kerstens MN et al (2019) CT characteristics of pheochromocytoma: relevance for the evaluation of adrenal incidentaloma. J Clin Endocrinol Metab 104:312\u2013318. https:\/\/doi.org\/10.1210\/jc.2018-01532","journal-title":"J Clin Endocrinol Metab"},{"key":"2015_CR49","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1007\/s00261-020-02764-4","volume":"46","author":"S Kang","year":"2021","unstructured":"Kang S, Oh YL, Park SY (2021) Distinguishing pheochromocytoma from adrenal adenoma by using modified computed tomography criteria. Abdom Radiol (NY) 46:1082\u20131090. https:\/\/doi.org\/10.1007\/s00261-020-02764-4","journal-title":"Abdom Radiol (NY)"},{"key":"2015_CR50","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.2214\/AJR.17.18472","volume":"210","author":"MF Mohammed","year":"2018","unstructured":"Mohammed MF, ElBanna KY, Ferguson D, Harris A, Khosa F (2018) Pheochromocytomas versus adenoma: role of venous phase CT enhancement. AJR Am J Roentgenol 210:1073\u20131078. https:\/\/doi.org\/10.2214\/AJR.17.18472","journal-title":"AJR Am J Roentgenol"},{"key":"2015_CR51","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/RCT.0000000000000343","volume":"40","author":"BG Northcutt","year":"2016","unstructured":"Northcutt BG, Trakhtenbroit MA, Gomez EN, Fishman EK, Johnson PT (2016) Adrenal adenoma and pheochromocytoma: comparison of multidetector CT venous enhancement levels and washout characteristics. J Comput Assist Tomogr 40:194\u2013200. https:\/\/doi.org\/10.1097\/RCT.0000000000000343","journal-title":"J Comput Assist Tomogr"},{"key":"2015_CR52","doi-asserted-by":"publisher","first-page":"834","DOI":"10.2214\/AJR.12.9753","volume":"201","author":"BG Northcutt","year":"2013","unstructured":"Northcutt BG, Raman SP, Long C et al (2013) MDCT of adrenal masses: can dual-phase enhancement patterns be used to differentiate adenoma and pheochromocytoma? AJR Am J Roentgenol 201:834\u2013839. https:\/\/doi.org\/10.2214\/AJR.12.9753","journal-title":"AJR Am J Roentgenol"},{"key":"2015_CR53","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1530\/EC-19-0198","volume":"8","author":"M Goroshi","year":"2019","unstructured":"Goroshi M, Jadhav SS, Sarathi V et al (2019) Radiological differentiation of phaeochromocytoma from other malignant adrenal masses: importance of wash-in characteristics on multiphase CECT. Endocr Connect 8:898\u2013905. https:\/\/doi.org\/10.1530\/EC-19-0198","journal-title":"Endocr Connect"},{"key":"2015_CR54","doi-asserted-by":"publisher","first-page":"4353","DOI":"10.1007\/s00261-021-03121-9","volume":"46","author":"YY An","year":"2021","unstructured":"An YY, Yang GZ, Lin B et al (2021) Differentiation of lipid-poor adenoma from pheochromocytoma on biphasic contrast-enhanced CT. Abdom Radiol (NY) 46:4353\u20134361. https:\/\/doi.org\/10.1007\/s00261-021-03121-9","journal-title":"Abdom Radiol (NY)"},{"key":"2015_CR55","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1148\/radiol.2021210231","volume":"301","author":"Y Nagayama","year":"2021","unstructured":"Nagayama Y, Inoue T, Kato Y et al (2021) Relative enhancement ratio of portal venous phase to unenhanced CT in the diagnosis of lipid-poor adrenal adenomas. Radiology 301:360\u2013368. https:\/\/doi.org\/10.1148\/radiol.2021210231","journal-title":"Radiology"},{"key":"2015_CR56","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.1007\/s00261-022-03593-3","volume":"47","author":"S Jin","year":"2022","unstructured":"Jin S, Zhang H, Pan W et al (2022) Diagnostic value of the relative enhancement ratio of the portal venous phase to unenhanced CT in the identification of lipid-poor adrenal tumors. Abdom Radiol (NY) 47:3308\u20133317. https:\/\/doi.org\/10.1007\/s00261-022-03593-3","journal-title":"Abdom Radiol (NY)"},{"key":"2015_CR57","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/s0009-9260(97)80252-8","volume":"52","author":"JC Varghese","year":"1997","unstructured":"Varghese JC, Hahn PF, Papanicolaou N, Mayo-Smith WW, Gaa JA, Lee MJ (1997) MR differentiation of phaeochromocytoma from other adrenal lesions based on qualitative analysis of T2 relaxation times. Clin Radiol 52:603\u2013606. https:\/\/doi.org\/10.1016\/s0009-9260(97)80252-8","journal-title":"Clin Radiol"},{"key":"2015_CR58","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s40336-023-00608-x","volume":"12","author":"S Maurea","year":"2024","unstructured":"Maurea S, Attanasio L, Galatola R et al (2024) MR imaging characterization of pheochromocytoma: a comparison between typical and atypical tumor lesions. Clin Transl Imaging 12:337\u2013346. https:\/\/doi.org\/10.1007\/s40336-023-00608-x","journal-title":"Clin Transl Imaging"},{"key":"2015_CR59","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.2214\/AJR.16.17758","volume":"208","author":"N Schieda","year":"2017","unstructured":"Schieda N, Siegelman ES (2017) Update on CT and MRI of adrenal nodules. AJR Am J Roentgenol 208:1206\u20131217. https:\/\/doi.org\/10.2214\/AJR.16.17758","journal-title":"AJR Am J Roentgenol"},{"key":"2015_CR60","doi-asserted-by":"publisher","first-page":"8247","DOI":"10.1007\/s00330-022-08867-4","volume":"32","author":"R Gerson","year":"2022","unstructured":"Gerson R, Tu W, Abreu-Gomez J et al (2022) Evaluation of the T2-weighted (T2W) adrenal MRI calculator to differentiate adrenal pheochromocytoma from lipid-poor adrenal adenoma. Eur Radiol 32:8247\u20138255. https:\/\/doi.org\/10.1007\/s00330-022-08867-4","journal-title":"Eur Radiol"},{"key":"2015_CR61","doi-asserted-by":"publisher","first-page":"e200011","DOI":"10.1148\/rycan.2020200011","volume":"2","author":"W Tu","year":"2020","unstructured":"Tu W, Abreu-Gomez J, Udare A, Alrashed A, Schieda N (2020) Utility of T2-weighted MRI to differentiate adrenal metastases from lipid-poor adrenal adenomas. Radiol Imaging Cancer 2:e200011. https:\/\/doi.org\/10.1148\/rycan.2020200011","journal-title":"Radiol Imaging Cancer"},{"key":"2015_CR62","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.23.29727","volume":"222","author":"W Tu","year":"2024","unstructured":"Tu W, Badawy M, Carney BW et al (2024) Multicenter validation of a T2-weighted MRI calculator to differentiate adrenal adenoma from adrenal metastases. AJR Am J Roentgenol 222:e2329727. https:\/\/doi.org\/10.2214\/AJR.23.29727","journal-title":"AJR Am J Roentgenol"},{"key":"2015_CR63","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1007\/s00261-022-03447-y","volume":"47","author":"R Berry","year":"2022","unstructured":"Berry R, Busireddy K, Chu LC, Johnson PT, Fishman EK (2022) The good, the bad, and the ugly: uncommon CT appearances of pheochromocytoma. Abdom Radiol (NY) 47:1406\u20131413. https:\/\/doi.org\/10.1007\/s00261-022-03447-y","journal-title":"Abdom Radiol (NY)"},{"key":"2015_CR64","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s00261-020-02464-z","volume":"45","author":"PJ Mazzaglia","year":"2020","unstructured":"Mazzaglia PJ, Varghese J, Habra MA (2020) Evaluation and management of adrenal neoplasms: endocrinologist and endocrine surgeon perspectives. Abdom Radiol (NY) 45:1001\u20131010. https:\/\/doi.org\/10.1007\/s00261-020-02464-z","journal-title":"Abdom Radiol (NY)"},{"key":"2015_CR65","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1148\/radiol.12120110","volume":"266","author":"YA Choi","year":"2013","unstructured":"Choi YA, Kim CK, Park BK, Kim B (2013) Evaluation of adrenal metastases from renal cell carcinoma and hepatocellular carcinoma: use of delayed contrast-enhanced CT. Radiology 266:514\u2013520. https:\/\/doi.org\/10.1148\/radiol.12120110","journal-title":"Radiology"},{"key":"2015_CR66","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1177\/0284185115572207","volume":"57","author":"B Moosavi","year":"2016","unstructured":"Moosavi B, Shabana WM, El-Khodary M et al (2016) Intracellular lipid in clear cell renal cell carcinoma tumor thrombus and metastases detected by chemical shift (in and opposed phase) MRI: radiologic-pathologic correlation. Acta Radiol 57:241\u2013248. https:\/\/doi.org\/10.1177\/0284185115572207","journal-title":"Acta Radiol"},{"key":"2015_CR67","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1530\/EJE-21-0650","volume":"186","author":"W Schloetelburg","year":"2021","unstructured":"Schloetelburg W, Ebert I, Petritsch B et al (2021) Adrenal wash-out CT: moderate diagnostic value in distinguishing benign from malignant adrenal masses. Eur J Endocrinol 186:183\u2013193. https:\/\/doi.org\/10.1530\/EJE-21-0650","journal-title":"Eur J Endocrinol"},{"key":"2015_CR68","doi-asserted-by":"publisher","first-page":"804","DOI":"10.2214\/AJR.22.27901","volume":"219","author":"MT Corwin","year":"2022","unstructured":"Corwin MT, Badawy M, Caoili EM (2022) Incidental adrenal nodules in patients without known malignancy: prevalence of malignancy and utility of washout CT for characterization\u2014a multiinstitutional study. AJR Am J Roentgenol 219:804\u2013812. https:\/\/doi.org\/10.2214\/AJR.22.27901","journal-title":"AJR Am J Roentgenol"},{"key":"2015_CR69","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.2214\/AJR.20.24417","volume":"216","author":"MT Corwin","year":"2021","unstructured":"Corwin MT, Remer EM (2021) Adrenal washout CT: point-not useful for characterizing incidentally discovered adrenal nodules. AJR Am J Roentgenol 216:1166\u20131167. https:\/\/doi.org\/10.2214\/AJR.20.24417","journal-title":"AJR Am J Roentgenol"},{"key":"2015_CR70","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1007\/s00261-024-04333-5","volume":"49","author":"T van Aswegen","year":"2024","unstructured":"van Aswegen T, Trinh B, Jacques A, Lo G (2024) Adrenal washout CT in patients with no history of cancer: a waste of time? Abdom Radiol (NY) 49:3117\u20133126. https:\/\/doi.org\/10.1007\/s00261-024-04333-5","journal-title":"Abdom Radiol (NY)"},{"key":"2015_CR71","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1530\/EC-20-0196","volume":"9","author":"JS Lim","year":"2020","unstructured":"Lim JS, Lee SE, Kim JH, Kim JH (2020) Characteristics of adrenocortical carcinoma in South Korea: a registry-based nationwide survey. Endocr Connect 9:519\u2013529. https:\/\/doi.org\/10.1530\/EC-20-0196","journal-title":"Endocr Connect"},{"key":"2015_CR72","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s00261-019-02371-y","volume":"45","author":"AA Ahmed","year":"2020","unstructured":"Ahmed AA, Thomas AJ, Ganeshan DM et al (2020) Adrenal cortical carcinoma: pathology, genomics, prognosis, imaging features, and mimics with impact on management. Abdom Radiol (NY) 45:945\u2013963. https:\/\/doi.org\/10.1007\/s00261-019-02371-y","journal-title":"Abdom Radiol (NY)"},{"key":"2015_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2024.102077","volume":"22","author":"HA Yasar","year":"2024","unstructured":"Yasar HA, Aktas BY, Ucar G (2024) Adrenocortical cancer in the real world: a comprehensive analysis of clinical features and management from the Turkish Oncology Group (TOG). Clin Genitourin Cancer 22:102077. https:\/\/doi.org\/10.1016\/j.clgc.2024.102077","journal-title":"Clin Genitourin Cancer"},{"key":"2015_CR74","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1067\/msy.1998.92009","volume":"124","author":"JE Lee","year":"1998","unstructured":"Lee JE, Evans DB, Hickey RC et al (1998) Unknown primary cancer presenting as an adrenal mass: frequency and implications for diagnostic evaluation of adrenal incidentalomas. Surgery 124:1115\u20131122. https:\/\/doi.org\/10.1067\/msy.1998.92009","journal-title":"Surgery"},{"key":"2015_CR75","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/S2213-8587(20)30314-4","volume":"8","author":"A Ebbehoj","year":"2020","unstructured":"Ebbehoj A, Li D, Kaur RJ et al (2020) Epidemiology of adrenal tumours in Olmsted County, Minnesota, USA: a population-based cohort study. Lancet Diabetes Endocrinol 8:894\u2013902. https:\/\/doi.org\/10.1016\/S2213-8587(20)30314-4","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2015_CR76","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/S2213-8587(20)30218-7","volume":"8","author":"I Bancos","year":"2020","unstructured":"Bancos I, Taylor AE, Chortis V et al (2020) Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study. Lancet Diabetes Endocrinol 8:773\u2013781. https:\/\/doi.org\/10.1016\/S2213-8587(20)30218-7","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2015_CR77","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1530\/EJE-17-1056","volume":"178","author":"M Marty","year":"2018","unstructured":"Marty M, Gaye D, Perez P et al (2018) Diagnostic accuracy of computed tomography to identify adenomas among adrenal incidentalomas in an endocrinological population. Eur J Endocrinol 178:439\u2013446. https:\/\/doi.org\/10.1530\/EJE-17-1056","journal-title":"Eur J Endocrinol"},{"key":"2015_CR78","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1530\/EJE-17-0372","volume":"177","author":"AR Hong","year":"2017","unstructured":"Hong AR, Kim JH, Park KS et al (2017) Optimal follow-up strategies for adrenal incidentalomas: reappraisal of the 2016 ESE-ENSAT guidelines in real clinical practice. Eur J Endocrinol 177:475\u2013483. https:\/\/doi.org\/10.1530\/EJE-17-0372","journal-title":"Eur J Endocrinol"},{"key":"2015_CR79","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.mayocpiqo.2017.11.002","volume":"2","author":"NM I\u00f1iguez-Ariza","year":"2017","unstructured":"I\u00f1iguez-Ariza NM, Kohlenberg JD, Delivanis DA et al (2017) Clinical, biochemical, and radiological characteristics of a single-center retrospective cohort of 705 large adrenal tumors. Mayo Clin Proc Innov Qual Outcomes 2:30\u201339. https:\/\/doi.org\/10.1016\/j.mayocpiqo.2017.11.002","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"2015_CR80","doi-asserted-by":"publisher","first-page":"4338","DOI":"10.1007\/s00261-021-03110-","volume":"46","author":"MT Corwin","year":"2021","unstructured":"Corwin MT, Lan C, Wilson M, Loehfelm TW, Campbell MJ (2021) Can abdominal CT features predict autonomous cortisol secretion in patients with adrenal nodules? Abdom Radiol (NY) 46:4338\u20134344. https:\/\/doi.org\/10.1007\/s00261-021-03110-","journal-title":"Abdom Radiol (NY)"},{"key":"2015_CR81","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.3390\/ijerph16101872","volume":"16","author":"E Cyranska-Chyrek","year":"2019","unstructured":"Cyranska-Chyrek E, Szczepanek-Parulska E, Olejarz M, Ruchala M (2019) Malignancy risk and hormonal activity of adrenal incidentalomas in a large cohort of patients from a single tertiary reference center. Int J Environ Res Public Health 16:1872. https:\/\/doi.org\/10.3390\/ijerph16101872","journal-title":"Int J Environ Res Public Health"},{"key":"2015_CR82","doi-asserted-by":"publisher","first-page":"632","DOI":"10.2214\/AJR.19.21342","volume":"213","author":"MT Corwin","year":"2019","unstructured":"Corwin MT, Navarro SM, Malik DG et al (2019) Differences in growth rate on CT of adrenal adenomas and malignant adrenal nodules. AJR Am J Roentgenol 213:632\u2013636. https:\/\/doi.org\/10.2214\/AJR.19.21342","journal-title":"AJR Am J Roentgenol"},{"key":"2015_CR83","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.794197","volume":"12","author":"F Ceccato","year":"2021","unstructured":"Ceccato F, Tizianel I, Voltan G et al (2021) Attenuation value in adrenal incidentalomas: a longitudinal study. Front Endocrinol 12:794197. https:\/\/doi.org\/10.3389\/fendo.2021.794197","journal-title":"Front Endocrinol"},{"key":"2015_CR84","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2214\/AJR.09.2592","volume":"193","author":"BM Yeh","year":"2009","unstructured":"Yeh BM, Shepherd JA, Wang ZJ, Teh HS, Hartman RP, Prevrhal S (2009) Dual-energy and low-kVp CT in the abdomen. AJR Am J Roentgenol 193:47\u201354. https:\/\/doi.org\/10.2214\/AJR.09.2592","journal-title":"AJR Am J Roentgenol"},{"key":"2015_CR85","doi-asserted-by":"publisher","first-page":"4345","DOI":"10.1007\/s00261-021-03062-3","volume":"46","author":"J Cao","year":"2021","unstructured":"Cao J, Lennartz S, Parakh A et al (2021) Dual-layer dual-energy CT for characterization of adrenal nodules: can virtual unenhanced images replace true unenhanced acquisitions? Abdom Radiol (NY) 46:4345\u20134352. https:\/\/doi.org\/10.1007\/s00261-021-03062-3","journal-title":"Abdom Radiol (NY)"},{"key":"2015_CR86","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1148\/radiol.2020192227","volume":"296","author":"Y Nagayama","year":"2020","unstructured":"Nagayama Y, Inoue T, Oda S et al (2020) Adrenal adenomas versus metastases: diagnostic performance of dual-energy spectral CT virtual noncontrast imaging and iodine maps. Radiology 296:324\u2013332. https:\/\/doi.org\/10.1148\/radiol.2020192227","journal-title":"Radiology"},{"key":"2015_CR87","doi-asserted-by":"publisher","first-page":"5944","DOI":"10.1007\/s00330-024-10675-x","volume":"34","author":"S Bette","year":"2024","unstructured":"Bette S, Risch F, Canalini L et al (2024) Diagnostic performance of photon-counting detector CT for differentiation between adrenal adenomas and metastases. Eur Radiol 34:5944\u20135953. https:\/\/doi.org\/10.1007\/s00330-024-10675-x","journal-title":"Eur Radiol"},{"key":"2015_CR88","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.23.30769","volume":"222","author":"MT Corwin","year":"2024","unstructured":"Corwin MT, Caoili EM, Elsayes KM et al (2024) Performance of CT with adrenal-washout protocol in heterogeneous adrenal nodules: a multiinstitutional study. AJR Am J Roentgenol 222:e2330769. https:\/\/doi.org\/10.2214\/AJR.23.30769","journal-title":"AJR Am J Roentgenol"},{"key":"2015_CR89","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.2214\/AJR.12.10302","volume":"201","author":"JH Song","year":"2013","unstructured":"Song JH, Grand DJ, Beland MD, Chang KJ, Machan JT, Mayo-Smith WW (2013) Morphologic features of 211 adrenal masses at initial contrast-enhanced CT: can we differentiate benign from malignant lesions using imaging features alone? AJR Am J Roentgenol 201:1248\u20131253. https:\/\/doi.org\/10.2214\/AJR.12.10302","journal-title":"AJR Am J Roentgenol"},{"key":"2015_CR90","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.2214\/AJR.17.19276","volume":"211","author":"W Tu","year":"2018","unstructured":"Tu W, Verma R, Krishna S, McInnes MDF, Flood TA, Schieda N (2018) Can adrenal adenomas be differentiated from adrenal metastases at single-phase contrast-enhanced CT? AJR Am J Roentgenol 211:1044\u20131050. https:\/\/doi.org\/10.2214\/AJR.17.19276","journal-title":"AJR Am J Roentgenol"},{"key":"2015_CR91","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1007\/s00261-020-02925-5","volume":"46","author":"MT Corwin","year":"2021","unstructured":"Corwin MT, Mitchell AS, Wilson M, Campbell MJ, Fananapazir G, Loehfelm TW (2021) Accuracy of focal cystic appearance within adrenal nodules on contrast-enhanced CT to distinguish pheochromocytoma and malignant adrenal tumors from adenomas. Abdom Radiol (NY) 46:2683\u20132689. https:\/\/doi.org\/10.1007\/s00261-020-02925-5","journal-title":"Abdom Radiol (NY)"},{"key":"2015_CR92","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.2214\/ajr.180.6.1801649","volume":"180","author":"F Fujiyoshi","year":"2003","unstructured":"Fujiyoshi F, Nakajo M, Fukukura Y, Tsuchimochi S (2003) Characterization of adrenal tumors by chemical shift fast low-angle shot MR imaging: comparison of four methods of quantitative evaluation. AJR Am J Roentgenol 180:1649\u20131657. https:\/\/doi.org\/10.2214\/ajr.180.6.1801649","journal-title":"AJR Am J Roentgenol"},{"key":"2015_CR93","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1007\/s00330-018-5626-5","volume":"29","author":"I Platzek","year":"2019","unstructured":"Platzek I, Sieron D, Plodeck V et al (2019) Chemical shift imaging for evaluation of adrenal masses: a systematic review and meta-analysis. Eur Radiol 29:806\u2013817. https:\/\/doi.org\/10.1007\/s00330-018-5626-5","journal-title":"Eur Radiol"},{"key":"2015_CR94","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1148\/radiol.2313030676","volume":"231","author":"MA Haider","year":"2004","unstructured":"Haider MA, Ghai S, Jhaveri K, Lockwood G (2004) Chemical shift MR imaging of hyperattenuating (>\u200910 HU) adrenal masses: does it still have a role? Radiology 231:711\u2013716. https:\/\/doi.org\/10.1148\/radiol.2313030676","journal-title":"Radiology"},{"key":"2015_CR95","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1148\/radiol.2433051978","volume":"243","author":"BK Park","year":"2007","unstructured":"Park BK, Kim CK, Kim B, Lee JH (2007) Comparison of delayed enhanced CT and chemical shift MR for evaluating hyperattenuating incidental adrenal masses. Radiology 243:760\u2013765. https:\/\/doi.org\/10.1148\/radiol.2433051978","journal-title":"Radiology"},{"key":"2015_CR96","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1007\/s00330-013-3084-7","volume":"24","author":"HJ Koo","year":"2014","unstructured":"Koo HJ, Choi HJ, Kim HJ, Kim SO, Cho KS (2014) The value of 15-minute delayed contrast-enhanced CT to differentiate hyperattenuating adrenal masses compared with chemical shift MR imaging. Eur Radiol 24:1410\u20131420. https:\/\/doi.org\/10.1007\/s00330-013-3084-7","journal-title":"Eur Radiol"},{"key":"2015_CR97","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.2214\/AJR.13.11389","volume":"202","author":"JM Seo","year":"2014","unstructured":"Seo JM, Park BK, Park SY, Kim CK (2014) Characterization of lipid-poor adrenal adenoma: chemical-shift MRI and washout CT. AJR Am J Roentgenol 202:1043\u20131050. https:\/\/doi.org\/10.2214\/AJR.13.11389. Erratum in: AJR Am J Roentgenol 212:232","journal-title":"AJR Am J Roentgenol"},{"key":"2015_CR98","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1148\/radiol.2021202435","volume":"301","author":"Y Nagayama","year":"2021","unstructured":"Nagayama Y, Inoue T, Oda S et al (2021) Unenhanced dual-layer spectral-detector CT for characterizing indeterminate adrenal lesions. Radiology 301:369\u2013378. https:\/\/doi.org\/10.1148\/radiol.2021202435","journal-title":"Radiology"},{"key":"2015_CR99","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1007\/s00330-024-10929-8","volume":"35","author":"Y Nagayama","year":"2025","unstructured":"Nagayama Y, Uchimura R, Maruyama N et al (2025) Non-contrast spectral CT vs chemical-shift MRI in discriminating lipid-poor adrenal lesions. Eur Radiol 35:370\u2013380. https:\/\/doi.org\/10.1007\/s00330-024-10929-8","journal-title":"Eur Radiol"},{"key":"2015_CR100","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1148\/radiol.11100569","volume":"259","author":"GW Boland","year":"2011","unstructured":"Boland GW, Dwamena BA, Jagtiani Sangwaiya M et al (2011) Characterization of adrenal masses by using FDG PET: a systematic review and meta-analysis of diagnostic test performance. Radiology 259:117\u2013126. https:\/\/doi.org\/10.1148\/radiol.11100569","journal-title":"Radiology"},{"key":"2015_CR101","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/cen.13448","volume":"88","author":"DA Delivanis","year":"2018","unstructured":"Delivanis DA, Bancos I, Atwell TD et al (2018) Diagnostic performance of unenhanced computed tomography and 18F-fluorodeoxyglucose positron emission tomography in indeterminate adrenal tumours. Clin Endocrinol 88:30\u201336. https:\/\/doi.org\/10.1111\/cen.13448","journal-title":"Clin Endocrinol"},{"key":"2015_CR102","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1210\/clinem\/dgad138","volume":"108","author":"M Schaafsma","year":"2023","unstructured":"Schaafsma M, Berends AMA, Links TP, Brouwers AH, Kerstens MN (2023) The diagnostic value of 18F-FDG PET\/CT scan in characterizing adrenal tumors. J Clin Endocrinol Metab 108:2435\u20132445. https:\/\/doi.org\/10.1210\/clinem\/dgad138","journal-title":"J Clin Endocrinol Metab"},{"key":"2015_CR103","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1530\/EC-19-0204","volume":"8","author":"G Akku\u015f","year":"2019","unstructured":"Akku\u015f G, G\u00fcney IB, Ok F et al (2019) Diagnostic efficacy of 18F-FDG PET\/CT in patients with adrenal incidentaloma. Endocr Connect 8:838\u2013845. https:\/\/doi.org\/10.1530\/EC-19-0204","journal-title":"Endocr Connect"},{"key":"2015_CR104","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1097\/RLU.0000000000002759","volume":"44","author":"R Murayama","year":"2019","unstructured":"Murayama R, Nishie A, Hida T et al (2019) Uptake of 18F-FDG in adrenal adenomas is associated with unenhanced CT value and constituent cells. Clin Nucl Med 44:943\u2013948. https:\/\/doi.org\/10.1097\/RLU.0000000000002759","journal-title":"Clin Nucl Med"},{"key":"2015_CR105","first-page":"972","volume":"45","author":"H Minn","year":"2004","unstructured":"Minn H, Salonen A, Friberg J et al (2004) Imaging of adrenal incidentalomas with PET using 11C-metomidate and 18F-FDG. J Nucl Med 45:972\u2013979","journal-title":"J Nucl Med"},{"key":"2015_CR106","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s12020-020-02474-3","volume":"70","author":"SM Chen Cardenas","year":"2020","unstructured":"Chen Cardenas SM, Santhanam P (2020) 11C-metomidate PET in the diagnosis of adrenal masses and primary aldosteronism: a review of the literature. Endocrine 70:479\u2013487. https:\/\/doi.org\/10.1007\/s12020-020-02474-3","journal-title":"Endocrine"},{"key":"2015_CR107","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41591-022-02114-5","volume":"29","author":"X Wu","year":"2023","unstructured":"Wu X, Senanayake R, Goodchild E et al (2023) [11C]metomidate PET-CT versus adrenal vein sampling for diagnosing surgically curable primary aldosteronism: a prospective, within-patient trial. Nat Med 29:190\u2013202. https:\/\/doi.org\/10.1038\/s41591-022-02114-5","journal-title":"Nat Med"},{"key":"2015_CR108","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.diii.2022.09.003","volume":"104","author":"M Barat","year":"2023","unstructured":"Barat M, Gaillard M, Cottereau AS et al (2023) Artificial intelligence in adrenal imaging: a critical review of current applications. Diagn Interv Imaging 104:37\u201342. https:\/\/doi.org\/10.1016\/j.diii.2022.09.003","journal-title":"Diagn Interv Imaging"}],"container-title":["Insights into Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-025-02015-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13244-025-02015-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-025-02015-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T15:35:17Z","timestamp":1751038517000},"score":1,"resource":{"primary":{"URL":"https:\/\/insightsimaging.springeropen.com\/articles\/10.1186\/s13244-025-02015-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,27]]},"references-count":108,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2015"],"URL":"https:\/\/doi.org\/10.1186\/s13244-025-02015-4","relation":{},"ISSN":["1869-4101"],"issn-type":[{"value":"1869-4101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,27]]},"assertion":[{"value":"25 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"136"}}